Sunday, 22 October 2017
News with tag FDA  RSS
Gene therapy for blood cancer wins FDA approval

Added: 19.10.2017 15:41 | 9 views | 0 comments

Customized "living drug" treatment for lymphoma is expected to cost $373,000 per patient

From: feeds.cbsnews.com

FDA Okays 2nd Gene Therapy for Cancer

Added: 19.10.2017 15:33 | 7 views | 0 comments

The FDA approved a second CAR-T treatment for cancer, described as gene therapy, to fight a type of B-cell lymphoma.

From: https:

FDA Okays 2nd Gene Therapy for Cancer

Added: 19.10.2017 15:21 | 21 views | 0 comments

The FDA approved a second CAR-T treatment for cancer, described as gene therapy, to fight a type of B-call lymphoma.

From: https:

FDA approves Gilead cancer gene therapy; price set at $373,000

Added: 19.10.2017 5:32 | 9 views | 0 comments

U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.

From: feeds.foxbusiness.com

FDA approves 2nd gene therapy for blood cancer, this one for aggressive lymphoma in adults

Added: 19.10.2017 2:40 | 17 views | 0 comments


U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.
The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy...

From: www.sun-sentinel.com

FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Added: 18.10.2017 23:37 | 9 views | 0 comments

U.S. regulators have approved a second gene therapy for blood cancer.

From: feeds.foxbusiness.com

FDA selects Box to help it modernize IT infrastructure

Added: 18.10.2017 14:11 | 10 views | 0 comments

The deal is strategically important for Box as it grows its business in both the government and life sciences sectors.

From: www.zdnet.com

Why TransEnterix Stock Is Soaring Today

Added: 17.10.2017 18:19 | 7 views | 0 comments

TransEnterix's stock keeps moving higher in the wake of the FDA clearing its novel robotic surgery device.

From: feeds.foxbusiness.com

Rapamycin treatment prevents crippling abnormal bone formation after severe limb injuries

Added: 16.10.2017 18:20 | 3 views | 0 comments

Individuals with severe injuries to their extremities often develop abnormal extra-skeletal bone in damaged or healing tissue, known as heterotopic ossification (HO). This post-traumatic abnormal wound healing can interfere with recovery, causing chronic pain, reduced mobility, and impaired prosthetic limb function. Rapamycin, an FDA-approved drug already on the market, was found to dramatically reduce the presence of HO in rats, suggesting it has potential to become the first effective treatment to prevent HO.

Tags: FDA
From: https:

Pioneering gene therapy approved for leukaemia in the US

Added: 16.10.2017 2:22 | 8 views | 0 comments

CAR-T treatments fight cancer by genetically modifying a person’s own immune cells. A CAR-T therapy has now been approved by the FDA – but it costs $475,000

From: https:

Older articles »
advertising
White House Video of the Day

Copyright © 2008-2017 USweekly  - all rights reserved